Global Single-Use Bioprocess Tubing Market Strategic Research Report
By Type: Silicone Tubing, TPE Tubing, PVC Tubing, PE Tubing, Others
By Application: Biopharmaceutical Companies, Vaccine Manufacturing Organizations, Cell and Gene Therapy Companies, CDMO / CMO Institutions, Research Institutes and Laboratories
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Saint-Gobain, Merck Millipore, Sartorius, Thermo Fisher Scientific, Danaher (Cytiva), Pall, Repligen, Avantor, Entegris, Watson-Marlow, Corning, Freudenberg Medical, DuPont, Trelleborg Medical Solutions
نظرة عامة
Scope of the Report
The global Single-Use Bioprocess Tubing market size is predicted to grow from US$ 372 million in 2025 to US$ 529 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.
In 2025, global production capacity for single-use bioprocess tubing reached approximately 35 million meters, with actual production around 24 million meters. The average global market price is around US$ 12 per meter, and the market gross margin mainly ranges between 30% and 50%. Single-use bioprocess tubing is a flexible, sterile tubing used in disposable bioprocessing systems for the transfer of liquids, buffers, cell cultures, and media. Designed for single-use applications, these tubing systems eliminate cross-contamination risks, reduce cleaning and validation requirements, and enhance operational flexibility in biopharmaceutical manufacturing. They are widely applied in cell culture, fermentation, filtration, mixing, and filling processes, supporting modular and scalable production workflows while maintaining sterility and compliance with regulatory standards.
The upstream of the single-use bioprocess tubing industry mainly includes medical-grade polymers, elastomers, fittings, connectors, and sterilization materials. Midstream focuses on tubing extrusion, assembly with connectors, sterilization, quality control, and validation to meet GMP and regulatory compliance. Downstream serves biopharmaceutical manufacturers, CDMOs, and research facilities, integrating tubing into single-use assemblies, bioreactors, and fluid transfer systems. The industry features high regulatory requirements, specialized precision manufacturing, and increasing adoption of modular and disposable production systems, with service and customization opportunities growing alongside.
The single-use bioprocess tubing market is driven by the growth of biologics, vaccines, and cell and gene therapies, as well as the industry’s shift toward disposable and modular manufacturing systems. Single-use tubing reduces the risk of cross-contamination, minimizes cleaning and validation efforts, and enables flexible, scalable production workflows. Regulatory compliance, including FDA, EMA, and ISO standards, strongly influences material selection, design, and sterilization methods. Technological innovations, such as low-extractables materials, pre-sterilized assemblies, and integrated tubing sets, further stimulate adoption. The expansion of contract manufacturing, continuous bioprocessing, and flexible production facilities has increased demand for reliable, prevalidated tubing solutions. Additionally, rising focus on operational efficiency and cost reduction supports the replacement of traditional stainless-steel piping with single-use systems, ensuring stable and growing demand for high-quality bioprocess tubing worldwide.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Single-Use Bioprocess Tubing market?
What factors are driving Single-Use Bioprocess Tubing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Single-Use Bioprocess Tubing market opportunities vary by end market size?
How does Single-Use Bioprocess Tubing break out by Type, by Application?
This report presents a comprehensive overview of the global Single-Use Bioprocess Tubing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Silicone Tubing
- TPE Tubing
- PVC Tubing
- PE Tubing
- Others
Segment by Sterilization Method
- Gamma-Sterilized Tubing
- Autoclavable Tubing
Segment by Application
- Biopharmaceutical Companies
- Vaccine Manufacturing Organizations
- Cell and Gene Therapy Companies
- CDMO / CMO Institutions
- Research Institutes and Laboratories
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Single-Use Bioprocess Tubing market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Biopharmaceutical Companies, Vaccine Manufacturing Organizations, Cell and Gene Therapy Companies evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Single-Use Bioprocess Tubing Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Silicone Tubing
- 3.1.3 TPE Tubing
- 3.1.4 PVC Tubing
- 3.1.5 PE Tubing
- 3.1.6 Others
- 3.1.7 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Biopharmaceutical Companies
- 4.1.3 Vaccine Manufacturing Organizations
- 4.1.4 Cell and Gene Therapy Companies
- 4.1.5 CDMO / CMO Institutions
- 4.1.6 Research Institutes and Laboratories
- 4.1.7 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Saint-Gobain
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Merck Millipore
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Sartorius
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Thermo Fisher Scientific
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Danaher (Cytiva)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Pall
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Repligen
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Avantor
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Entegris
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Watson-Marlow
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Corning
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Freudenberg Medical
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 DuPont
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Trelleborg Medical Solutions
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Single-Use Bioprocess Tubing market?
How fast is the Single-Use Bioprocess Tubing market expected to grow?
What does the Single-Use Bioprocess Tubing market cover?
How is the Single-Use Bioprocess Tubing market segmented by type?
What are the key applications of Single-Use Bioprocess Tubing?
Which companies are profiled in the Single-Use Bioprocess Tubing market report?
What geographies does the Single-Use Bioprocess Tubing market analysis include?
What are the key demand drivers for Single-Use Bioprocess Tubing?
Who should buy the Single-Use Bioprocess Tubing market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Single-Use Bioprocess Tubing Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Biotechnology & Life Sciences